QIAGEN (ETR:QIA) Rating Kept

ETR:QIA is at the moment trading 1.49% higher at EUR 27.27 as of 6:05 PM Frankfurt time. QIAGEN’s stock is 0% over the last 200 days. It has underperformed the Standard & Poor’s 500 index, which has added 8.57% over the same time.

QIAGEN (ETR:QIA) Profile

QIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems.

QIAGEN (ETR:QIA) traded up 1.49% on 2 February, hitting EUR 27.27. A total of 891,716 shares of the company’s stock traded hands. This is up from average of 326,223 shares. QIAGEN has a 52 week low of EUR 18.44 and a 52 week high of EUR 28.73. The company has a market cap of 6.30B EUR and a P/E ratio of 56.62.

Get the latest QIAGEN (ETR:QIA) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post S&P Capital IQ Reiterated QIAGEN (ETR:QIA) As “Hold”; Has TP Of EUR 28.00 appeared first on Octafinance.